NewAmsterdam Pharma Corporation (@newamspharma) 's Twitter Profile
NewAmsterdam Pharma Corporation

@newamspharma

NewAmsterdam Pharma Corporation is a late-stage clinical biopharma company developing therapies for cardiometabolic diseases. Intended for US audiences only.

ID: 1424851352463753221

linkhttps://www.newamsterdampharma.com/ calendar_today09-08-2021 21:54:12

376 Tweet

873 Followers

111 Following

NewAmsterdam Pharma Corporation (@newamspharma) 's Twitter Profile Photo
NewAmsterdam Pharma Corporation
@newamspharma

2 months ago

Heterozygous familial hypercholesterolemia (HeFH) is a common genetic condition characterized by very high LDL-C levels. Our Phase 3 BROOKLYN study reported positive results this week on LDL-C reduction in HeFH.